Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shenqi Fuzheng Injection for Cancer-related Fatigue in GI Cancer
NCT03455205Unknown
- Sponsor
- Livzon Pharmaceutical Group Inc.
- Start
- Dec 2017
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in cancer-related fatigue (CRF) comparing Shenqi Fuzheng + Chemo with Placebo + Chemo (2 arms). Primary endpoint: Piper Fatigue Scale at 42 days. Status: unknown.
02
Drugs
shenqi fuzheng injection
03
Conditions
cancer-related fatigue (CRF)
Beyond the preview
Go deeper on NCT03455205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03455205.